High-dose budesonide for early COVID-19 - Authors' reply.
Saved in:
| Title: | High-dose budesonide for early COVID-19 - Authors' reply. |
|---|---|
| Authors: | Hobbs FDR; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: richard.hobbs@phc.ox.ac.uk., Yu LM; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK., Saville BR; Berry Consultants, Austin, TX, USA., Bafadhel M; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX2 6GG, UK., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. |
| Source: | Lancet (London, England) [Lancet] 2021 Dec 11; Vol. 398 (10317), pp. 2147-2148. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34895528 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High-dose budesonide for early COVID-19 - Authors' reply. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hobbs+FDR%22">Hobbs FDR</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. Electronic address: richard.hobbs@phc.ox.ac.uk.<br /><searchLink fieldCode="AU" term="%22Yu+LM%22">Yu LM</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK.<br /><searchLink fieldCode="AU" term="%22Saville+BR%22">Saville BR</searchLink>; Berry Consultants, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bafadhel+M%22">Bafadhel M</searchLink>; Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX2 6GG, UK.<br /><searchLink fieldCode="AU" term="%22Butler+CC%22">Butler CC</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2021 Dec 11; Vol. 398 (10317), pp. 2147-2148. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34895528 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(21)02449-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2147 Titles: – TitleFull: High-dose budesonide for early COVID-19 - Authors' reply. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hobbs FDR – PersonEntity: Name: NameFull: Yu LM – PersonEntity: Name: NameFull: Saville BR – PersonEntity: Name: NameFull: Bafadhel M – PersonEntity: Name: NameFull: Butler CC IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 12 Text: 2021 Dec 11 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 398 – Type: issue Value: 10317 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |